A carregar...
Cost-effectiveness of pemetrexed in combination with cisplatin as first line treatment for patients with advanced non-squamous non-small-cell lung cancer in Spain
Introduction: Lung cancer is the third most frequent neoplas-tic tumour in Spain, with around 27 000 new cases diagnosed per year; 80-95% of these are non-small-cell cancer (NSCLC), and the majority of cases are diagnosed in advanced stages of the disease, and for this reason it is one of the oncol...
Na minha lista:
| Publicado no: | Farmacia Hospitalaria |
|---|---|
| Main Authors: | , , , , , |
| Formato: | Artigo |
| Idioma: | Inglês |
| Publicado em: |
Sociedad Española de Farmacia Hospitalaria
2017
|
| Assuntos: | |
| Acesso em linha: | https://www.redalyc.org/articulo.oa?id=365962303002 https://www.redalyc.org/journal/3659/365962303002/ https://www.redalyc.org/journal/3659/365962303002/html/ https://www.redalyc.org/journal/3659/365962303002/365962303002.epub https://www.redalyc.org/journal/3659/365962303002/movil |
| Tags: |
Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!
|